Search results
Search list
Results in:
EGV 297/95
Council Regulation (EC) No 297/95 of 10 February 1995 on fees payable to the European Agency for the Evaluation of Medicinal Products
Edition
1995-02-10
EWGV 793/93Mitt 2008-06-18/1 ; 2008/C152/01:2008-05-21
Communication from the Commission on the results of the risk evaluation and the risk reduction strategies for the substances: chromium trioxide, ammonium dichromate, potassium dichromate
Edition
2008-05-21
EWGV 793/93Mitt 2008-06-18/2 ; 2008/C152/02:2008-06-18
Communication from the Commission on the results of the risk evaluation and the risk reduction strategies for the substances: sodium chromate, sodium dichromate and 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol (tetrabromobisphenol A)
Edition
2008-06-18
EWGV 793/93Mitt 2008-06-20 ; 2008/C155/01:2008-06-20
Communication from the Commission on the results of the risk evaluation and the risk reduction strategies for the substances: zinc oxide; zinc sulphate; trizinc bis(orthophosphate)
Edition
2008-06-20
EWGV 793/93Mitt 2008-06-21/1 ; 2008/C157/01:2008-06-21
Communication from the Commission on the results of the risk evaluation and the risk reduction strategies for the substances: trichloroethylene, benzene, 2-methoxy-2-methylbutane (TAME)
Edition
2008-06-21
EWGV 793/93Mitt 2008-06-21/2 ; 2008/C157/02:2008-06-21
Communication from the Commission on the results of the risk evaluation and the risk reduction strategies for the substances: 2,3-epoxypropyltrimethylammonium chloride (EPTAC), (3-chloro-2-hydroxypropyl)trimethylammonium chloride (CHPTAC) and hexachlorocyclopentadiene
Edition
2008-06-21
EWGV 793/93Mitt 2008-05 ; 2008/C131/04:2008-05-29
Communication from the Commission on the results of the risk evaluation of chlorodifluoromethane, bis(pentabromophenyl)ether and methenamine and on the risk reduction strategy for the substance methenamine
Edition
2008-05-29
EWGV 793/93Mitt 2008-06-14 ; 2008/C149/04:2008-06-14
Communication from the Commission on the results of the risk evaluation and the risk reduction strategies for the substances: benzyl butyl phthalate (BBP), 2-furaldehyde (furfural), perboric acid, sodium salt
Edition
2008-06-14
2001/194/EGEmpf
Commission Recommendation of 5 March 2001 on the results of the risk evaluation and the risk reduction strategies for the substances: diphenylether/pentabromo derivative and cumene
Edition
2001-03-05
2002/755/EGEmpf
Commission Recommendation of 16 September 2002 on the results of the risk evaluation and risk reduction strategy for the substance diphenyl ether, octabromo derivative
Edition
2002-09-16